Ramadoos urges PM to make sure GM mustard is not approved

Image
Press Trust of India New Delhi
Last Updated : Sep 22 2016 | 11:28 PM IST
Former Union Health minister Anbumani Ramadoss today sought urgent intervention of Prime Minister Narendra Modi to make sure that GM mustard is not approved by the country's biotech regulator GEAC.
In a letter to Modi, Ramadoss said that it is apparent that testing for GM mustard, which has received a safety clearance from a technical panel of experts in the Genetic Engineering Appraisal Committee (GEAC) has not been "adequate".
"When Bt brinjal was being debated for approval in India, as the then Union Health Minister, I had ensured that the ministry took a rigorous, pro-people and pro-science stand and I expect the Government to do the same with GM mustard, given that mustard is more widely grown and consumed and in more ways than Brinjal.
"If we want to protect citizens' health and environment, this GM mustard should not be approved at all and I urge you to intervene urgently and make sure that it is not permitted to be grown in India," Ramadoss said in his letter.
GEAC had constituted a sub-committee of scientific experts to examine the biosafety data on GM mustard.
After the committee examined it, the report was placed on the Environment Ministry's website inviting comments from stakeholders within a period of 30 days before the biotech regulator took a decision.
The report claimed that the hybrid variety did not pose any risk to biodiversity or agro-ecosystem.
Ramadoss said that he had also written to the Union Health Minister JP Nadda in November last year pointing out that there is absolutely no need for opting for this "unsafe" technology.
"In fact, the very basis on which this GM mustard is being pushed - its yield superiority - has not even been verified by the regulators," he said.
Ramadoss also said,"there are reports that the one health safety expert put into the technical panel represents a conflict of interest that should not have been there, and is also someone who did not participate in the assessment processes.
"Quite apart from this is the fact that GM mustard underwent very little testing on the health front," he said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 22 2016 | 11:28 PM IST

Next Story